Back to Search
CHRISTOPHER ZIELINSKI, DO
DO
Family Medicine Physician
NPI: 1235132622Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
05-37036(KS)2018036669(MO)
Research & Publications (20)
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.
PMID 19508170·Curr Cancer Drug Targets·2009
8-other
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.
PMID 18661231·Breast Cancer Res Treat·2009
3-trial
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
PMID 19636003·J Clin Oncol·2009
8-other
Management of cardiac adverse events occurring with sunitinib treatment.
PMID 19443377·Anticancer Res·2009
5-case
Third consensus on medical treatment of metastatic breast cancer.
PMID 19608616·Ann Oncol·2009
6-review
Absence of efficacy of thalidomide monotherapy in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
PMID 19654203·Ann Oncol·2009
8-other
Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
PMID 19608761·Blood·2009
8-other
Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells.
PMID 19467222·Biochem Biophys Res Commun·2009
8-other
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.
PMID 19289619·J Clin Oncol·2009
3-trial
Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapy.
PMID 19232474·Cancer Treat Rev·2009
6-review
Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
PMID 19222175·J Proteome Res·2009
7-preclinical
Synergistic effect of Sorafenib and Sunitinib with Enzastaurin, a selective protein kinase C inhibitor in renal cell carcinoma cell lines.
PMID 19171421·Cancer Lett·2009
8-other
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.
PMID 19389529·J Am Acad Dermatol·2009
5-case
Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent.
PMID 19042053·Lung Cancer·2009
3-trial
Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells.
PMID 19351150·J Proteome Res·2009
8-other
A phase II study of bortezomib in patients with MALT lymphoma.
PMID 19336742·Haematologica·2009
3-trial
Unilateral face swelling as first manifestation of metastatic pancreatic cancer: case report and review of the literature.
PMID 19116711·Wien Klin Wochenschr·2008
5-case
Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma.
PMID 18838713·J Clin Oncol·2008
8-other
[The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases].
PMID 18820857·Wien Klin Wochenschr·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1741 NE DOUGLAS ST STE 200
LEES SUMMIT, MO 64086 - Phone
- (816) 246-0200
Quick Facts
- NPI
- 1235132622
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile